Exclusive Pfizer

FILE - A vial of the Moderna COVID-19 vaccine is displayed on a counter at a pharmacy in Portland, Ore. on Dec. 27, 2021. A government advisory panel met Tuesday, June 14, 2022, to decide whether to recommend a second brand of COVID-19 vaccine for school-age children and teens. The Food and Drug Administration's outside experts will vote on whether Moderna's vaccine is safe and effective enough to give kids ages 6 to 17. If the panel endorses the shot and the FDA agrees, it would become the second option for those children, joining Pfizer's vaccine.(AP Photo/Jenny Kane, File)

FDA endorses Moderna, Pfizer vaccines for infants

Moderna plans to study its COVID-19 vaccine in infants as young as 3-months-old. The biotech company announced Wednesday that it will enroll as many as 700 babies in their experiment, dubbed Baby Cove, in September. The babies will reportedly receive two doses of Moderna’s vaccine within an eight-week period.